November 14, 2023 7:30am EST QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee
August 16, 2023 8:00am EDT QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
